A recent study proposed a new model of SCLC subtypes defined by the differential expressions of four key transcription regulators, ASCL1, NeuroD1, YAP1, and POU2F3, which would help to accelerate therapeutic research leading to targeted approaches [11]. This evidence concerns the gene YAP1 and small cell lung carcinoma.